Factorial Partners, LLC Collegium Pharmaceutical, Inc Transaction History

Factorial Partners, LLC

  • $156 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$14.22 - $20.88 $206,190 - $302,760
-14,500 Closed
0 $0
Q1 2022

May 03, 2022
SELL
$17.2 - $22.5 $323,360 - $423,000
-18,800 Reduced 56.46%
14,500 $295,000
Q4 2021

Feb 09, 2022
BUY
$17.5 - $21.35 $582,750 - $710,955
33,300 New
33,300 $622,000

Others Institutions Holding COLL

# of Institutions
256
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.05B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email